Literature DB >> 25164477

Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.

Shuja Ahmed1, John H Stewart, Perry Shen, Konstantinos I Votanopoulos, Edward A Levine.   

Abstract

Peritoneal metastasis (PM) has traditionally been approached with therapeutic nihilism. The evolution of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) over the last two decades, however, has caused a paradigm shift in treatment for PM. This modality is rapidly gaining acceptance as standard of care for PM from various cancers. This article reviews the current literature regarding the use of CRS/HIPEC for PM from the most common intra-abdominal malignancies.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal metastasis

Mesh：

Year:  2014        PMID： 25164477     DOI： 10.1002/jso.23749

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  13 in total

1.  Laparoscopic HIPEC: A bridge between open and closed-techniques.

Authors:  Marco Lotti; Michela Giulii Capponi; Dario Piazzalunga; Elia Poiasina; Michele Pisano; Roberto Manfredi; Luca Ansaloni
Journal:  J Minim Access Surg       Date:  2016 Jan-Mar       Impact factor: 1.407

2.  Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and Mortality.

Authors:  Carissa A Low; Dana H Bovbjerg; Steven Ahrendt; Sara Alhelo; Haroon Choudry; Matthew Holtzman; Heather L Jones; James F Pingpank; Lekshmi Ramalingam; Herbert J Zeh; Amer H Zureikat; David L Bartlett
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

Review 3.  Imaging of pre- and post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pediatric intraperitoneal malignancy.

Authors:  Nathan C Hull; Candace F Granberg; Patricio C Gargollo; Paul G Thacker
Journal:  Pediatr Radiol       Date:  2022-10-07

4.  A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery.

Authors:  Omar Abdel-Rahman
Journal:  Int J Colorectal Dis       Date:  2020-02-14       Impact factor: 2.571

5.  Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Kathleen A Cummins; Gregory B Russell; Konstantinos I Votanopoulos; Perry Shen; John H Stewart; Edward A Levine
Journal:  J Gastrointest Oncol       Date:  2016-02

Review 6.  Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future.

Authors:  Ahmed Dehal; J Joshua Smith; Garrett M Nash
Journal:  J Gastrointest Oncol       Date:  2016-02

7.  PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.

Authors:  Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger
Journal:  Ann Surg Oncol       Date:  2021-08-13       Impact factor: 5.344

8.  Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC).

Authors:  Mary Garland-Kledzik; Abhineet Uppal; Yalda B Naeini; Stacey Stern; Richard Erali; Anthony J Scholer; Adam M Khader; Juan A Santamaria-Barria; Kathleen Cummins-Perry; Yi Zhou; Konstantinos I Votanopoulos; Perry Shen; Edward A Levine; Anton J Bilchik
Journal:  J Gastrointest Surg       Date:  2020-12-02       Impact factor: 3.452

9.  Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis.

Authors:  Marcus Beck; Pirus Ghadjar; Mirko Weihrauch; Susen Burock; Volker Budach; Jacek Nadobny; Jalid Sehouli; Peter Wust
Journal:  Radiat Oncol       Date:  2015-07-30       Impact factor: 3.481

10.  Feasibility and acceptability of PrE-operative Physical Activity to improve patient outcomes After major cancer surgery: study protocol for a pilot randomised controlled trial (PEPA Trial).

Authors:  Daniel Steffens; Jane Young; Paula R Beckenkamp; James Ratcliffe; Freya Rubie; Nabila Ansari; Neil Pillinger; Michael Solomon
Journal:  Trials       Date:  2018-02-17       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.